如果企业客服不在线,也可拨打400电话联系。或者发布求购信息
JYQ-164 是一种针对人类的帕金森病蛋白 7 (PARK7/DJ-1) 小分子抑制剂。JYQ-164 通过共价和选择性地靶向 PARK7 的关键残基 Cys106 来发挥作用 (IC50=21 nM)。JYQ-164 对 PARK7 的高
mmu-miR-7681-5p inhibitor | MedChemExpress (MCE)
mmu-miR-7681-3p antagomir | MedChemExpress (MCE)
mmu-miR-7681-3p inhibitor | MedChemExpress (MCE)
mmu-miR-7680-5p antagomir | MedChemExpress (MCE)
mmu-miR-7680-5p inhibitor | MedChemExpress (MCE)
mmu-miR-7680-3p antagomir | MedChemExpress (MCE)
mmu-miR-7680-3p inhibitor | MedChemExpress (MCE)
mmu-miR-7679-5p antagomir | MedChemExpress (MCE)
mmu-miR-7679-5p inhibitor | MedChemExpress (MCE)
mmu-miR-7679-3p antagomir | MedChemExpress (MCE)